» Articles » PMID: 31541647

Color Doppler Duplex Ultrasound Parameters in Men Without Organic Erectile Dysfunction

Overview
Journal Urology
Specialty Urology
Date 2019 Sep 22
PMID 31541647
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To define age-specific normal Color Doppler Duplex Ultrasound (CDDU) parameters based on a large institutional database of men referred for vascular erectile testing, but found to have normal and sustained rigidity following penile injection of alprostadil.

Methods: A retrospective review of patients who underwent CDDU from January 1, 2005 to December 31, 2014 was conducted. The indications for CDDU assessments included complaint of erectile dysfunction refractory to PDE-5 inhibitors, new-onset penile curvature, or secondary consultation for erectile dysfunction. Pearson correlation test was used to evaluate the association between ordinal age groups with peak systolic velocity (PSV) and resistive index (RI) measurements to determine the effect of age on erectile response.

Results: A total of 2043 patients underwent CDDU from January 1, 2005 to December 31, 2014. 259 patients (12.7%) with a mean age 53.7 and a mean BMI of 27.2 were noted to have normal erectile rigidity and normal Doppler parameters (PSV >35 cm/s, RI >0.90). Prolonged erection, defined by need to inject phenylephrine reversal agent at 1-2 hours, occurred in 93% of patients. When age was categorized by decade, a negative correlation coefficient was obtained for previsual sexual stimulation PSV (-0.09, P = .164) and postvisual sexual stimulation PSV (-0.23, P = .005).

Conclusion: In men with normal vascular erections there appears to be a significant, age-related decline in postvisual sexual stimulation PSV without compromise to cavernous venous occlusion as measured by RI. We have used Doppler parameters in patients without vascular ED to define age-specific normalcy.

Citing Articles

Efficacy and safety of low-intensity pulsed ultrasound (LIPUS) combined with tadalafil in the treatment of severe erectile dysfunction: a retrospective cohort study.

Gao Q, Wang J, Li D, Dai Y, Li Z, Zhao X Transl Androl Urol. 2024; 13(9):2045-2054.

PMID: 39434752 PMC: 11491205. DOI: 10.21037/tau-24-154.


Novel predictive factor for erectile dysfunction: systemic immune inflammation index.

Gao H, Wu X, Zhang Y, Liu G, Zhang X Int J Impot Res. 2024; .

PMID: 39209960 DOI: 10.1038/s41443-024-00969-5.


[Retrospective study on the impact of penile corpus cavernosum injection test on penile vascular function].

Chen Y, Li K, Hong K, Zhang S, Cheng J, Zheng Z Beijing Da Xue Xue Bao Yi Xue Ban. 2024; 56(4):680-686.

PMID: 39041565 PMC: 11284470.


Specific gut microbiota may increase the risk of erectile dysfunction: a two-sample Mendelian randomization study.

Su Q, Long Y, Luo Y, Jiang T, Zheng L, Wang K Front Endocrinol (Lausanne). 2024; 14:1216746.

PMID: 38192423 PMC: 10773840. DOI: 10.3389/fendo.2023.1216746.


Analysis of the relationship between sexual satisfaction, erectile dysfunction, and penile vascular parameters in a cohort of patients.

Garcia-Gomez B, Alonso-Isa M, Celada-Luis G, Jauregibeitia-Ansotegi I, Garcia-Rojo E, Santos-Perez de la Blanca R Transl Androl Urol. 2022; 10(12):4313-4319.

PMID: 35070813 PMC: 8749074. DOI: 10.21037/tau-21-792.